These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

741 related articles for article (PubMed ID: 27452754)

  • 1. [Short-term efficacy comparison between preoperative three dimensional conformal radiotherapy and volumetric modulated arc therapy concurrently combined with chemotherapy in the treatment of locally advanced rectal carcinoma].
    Xiao L; Yu X; Zhu Y; Xiao W; Zeng Z; Liu M; Zhang R; Gao Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jul; 19(7):769-75. PubMed ID: 27452754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Feasibility study on Xelox (capecitabine plus oxapliplatin) in the volumetric modulated arc therapy (VMAT)-based preoperative chemoradiotherapy for locally advanced rectal cancer].
    Xiao L; Huang R; You K; Chang H; Qiu B; Xiao W; Chen L; Gao Y; Liu M
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Mar; 17(3):219-24. PubMed ID: 24671807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of volumetric-modulated arc therapy using simultaneous integrated boosts (SIB-VMAT) of 45 Gy/55 Gy in 25 fractions with conventional radiotherapy in preoperative chemoradiation for rectal cancers: a propensity score case-matched analysis.
    Yamashita H; Ishihara S; Nozawa H; Kawai K; Kiyomatsu T; Okuma K; Abe O; Watanabe T; Nakagawa K
    Radiat Oncol; 2017 Sep; 12(1):156. PubMed ID: 28934968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of the application among intensity-modulated radiotherapy, 3D-conformal radiotherapy and conventional radiotherapy for locally advanced middle-low rectal cancer].
    Zhang C; Dong J; Shen T; Li Y; Yang Z; Cheng X; Luo H; Yang J; Shi Z; Wang W; Zhang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Dec; 21(12):1414-1420. PubMed ID: 30588595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of dosimetric parameters and toxicity in esophageal cancer patients undergoing 3D conformal radiotherapy or VMAT.
    Münch S; Aichmeier S; Hapfelmeier A; Duma MN; Oechsner M; Feith M; Combs SE; Habermehl D
    Strahlenther Onkol; 2016 Oct; 192(10):722-9. PubMed ID: 27418129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative Volumetric Modulated Arc Therapy With Simultaneous Integrated Boost for Locally Advanced Distal Rectal Cancer.
    Yang Y; Liu Q; Jia B; Du X; Dai G; Liu H; Chen J; Zeng M; Wen K; Zhu Y; Wang Y; Feng L
    Technol Cancer Res Treat; 2019 Jan; 18():1533033818824367. PubMed ID: 30803368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moderate dose escalation with volumetric modulated arc therapy improves outcome in rectal cancer.
    Stuyck C; Wegge M; Bulens P; Joye I; Haustermans K
    Acta Oncol; 2017 Nov; 56(11):1501-1506. PubMed ID: 28826304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study of intensity modulated radiotherapy and three-dimensional conformal radiotherapy with three-dimensional brachytherapy and concurrent chemotherapy for patients with advanced cervical cancer].
    Du XX; Yang H; Zhang HJ; Li LA; Fan WS; Meng YG
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):679-686. PubMed ID: 29060966
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical Analysis of the Efficacy and Safety of Different Neoadjuvant Strategies in the Treatment of Locally Advanced Rectal Cancer.
    Chen W; Wang W; Huang S; Zhou L; Wang G; Chen W
    Cancer Invest; 2024 Aug; 42(7):661-670. PubMed ID: 39037150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3D conformal radiotherapy.
    Dröge LH; Weber HE; Guhlich M; Leu M; Conradi LC; Gaedcke J; Hennies S; Herrmann MK; Rave-Fränk M; Wolff HA
    BMC Cancer; 2015 Oct; 15():750. PubMed ID: 26486986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study.
    Picardi V; Macchia G; Guido A; Giaccherini L; Deodato F; Farioli A; Cilla S; Compagnone G; Ardizzoni A; Cuicchi D; Gambacorta MA; Cellini F; Frezza G; Poggioli G; Valentini V; Fuccio L; Morganti AG
    Clin Colorectal Cancer; 2017 Mar; 16(1):16-22. PubMed ID: 27435759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dosimetric comparison of double-arc volumetric arc therapy, step-shoot intensity modulated radiotherapy and 3D-CRT for left-sided breast cancer radiotherapy after breast-conserving surgery.
    Mo JC; Huang J; Gu WD; Gao M; Ning ZH; Mu JM; Li QL; Pei HL
    Technol Health Care; 2017 Oct; 25(5):851-858. PubMed ID: 29103057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of left sided breast cancer for a patient with funnel chest: volumetric-modulated arc therapy vs. 3D-CRT and intensity-modulated radiotherapy.
    Haertl PM; Pohl F; Weidner K; Groeger C; Koelbl O; Dobler B
    Med Dosim; 2013; 38(1):1-4. PubMed ID: 22727550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic body radiotherapy: volumetric modulated arc therapy versus 3D non-coplanar conformal radiotherapy for the treatment of early stage lung cancer.
    Herbert C; Kwa W; Nakano S; James K; Moiseenko V; Wu J; Schellenberg D; Liu M
    Technol Cancer Res Treat; 2013 Dec; 12(6):511-6. PubMed ID: 23617285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
    Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
    [No Abstract]   [Full Text] [Related]  

  • 16. Potential benefits of volumetric modulated arc therapy to reduce the incidence of ≥ grade 2 radiation pneumonitis in radiotherapy for locally advanced non-small cell lung cancer patients.
    Imano N; Kimura T; Kawahara D; Nishioka R; Fukumoto W; Kawano R; Kubo K; Katsuta T; Takeuchi Y; Nishibuchi I; Murakami Y; Horimasu Y; Masuda T; Fujitaka K; Hattori N; Nagata Y
    Jpn J Clin Oncol; 2021 Dec; 51(12):1729-1735. PubMed ID: 34625805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A randomized study of intensity-modulated radiation therapy versus three dimensional conformal radiation therapy for pelvic radiation in patients of post-operative treatment with gynecologic malignant tumor].
    Ni J; Yin ZM; Yuan SH; Liu NF; Li L; Xu XX; Lou HM
    Zhonghua Fu Chan Ke Za Zhi; 2017 Mar; 52(3):168-174. PubMed ID: 28355688
    [No Abstract]   [Full Text] [Related]  

  • 18. A phase II study of neoadjuvant chemoradiotherapy with oxaliplatin and capecitabine for rectal cancer.
    Zhao L; Bai C; Shao Y; Guan M; Jia N; Xiao Y; Qiu H; Zhang F; Yang T; Zhong G; Chen S
    Cancer Lett; 2011 Nov; 310(2):134-9. PubMed ID: 21782322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of 5-fluorouracil/leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer.
    Kim DY; Jung KH; Kim TH; Kim DW; Chang HJ; Jeong JY; Kim YH; Son SH; Yun T; Hong CW; Sohn DK; Lim SB; Choi HS; Jeong SY; Park JG
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):378-84. PubMed ID: 17097835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.